Loading...
Clinical Trials in Hepatocellular Carcinoma: An Update
The success of sorafenib has spurred an explosive increase of clinical trials testing novel molecular targets and other agents in the treatment of hepatocellular carcinoma (HCC). The paradigm of the studies has been characterized by three noticeable changes. First, the molecular targets of interest...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3881316/ https://ncbi.nlm.nih.gov/pubmed/24400222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000343850 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|